Search companies

Live

Tuesday, 17 November 2026 · 586 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

CONNEQT Expands U.S. Trial Contract By 33% To About $1 Million

CQT: $0.005 +25.00% · MC: $5M

CONNEQT Health has expanded its U.S. Phase 2b clinical trial contract by 33%, adding approximately US$0.24 million and lifting total contract value to approximately US$0.95 million. The amendment expands the trial from 30 to 45 sites, with revenue to be recognised over the trial period.

Source announcements: 2026-11-09 09:33 to 2026-11-09 09:33 Sydney time
Story updated 2026-11-09 09:38 Sydney time
SourcesExpansion of U.S. Phase 2B Clinical Trial Contract
Comments